Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 3/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 2/20 | 1.00 |
| ▸ | SCN5A | Q14524 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | ADRA2B | P18089 | 1/20 | 1.00 |
| ▸ | ADRA2C | P18825 | 1/20 | 1.00 |
| ▸ | DRD3 | P35462 | 1/20 | 1.00 |
| ▸ | OPRK1 | P41145 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | CACNA1F | O60840 | 1/20 | 1.00 |
| ▸ | SCN1A | P35498 | 1/20 | 1.00 |
| ▸ | SCN4A | P35499 | 1/20 | 1.00 |
| ▸ | SCN7A | Q01118 | 1/20 | 1.00 |
| ▸ | CACNA1D | Q01668 | 1/20 | 1.00 |
| ▸ | CACNA1S | Q13698 | 1/20 | 1.00 |
| ▸ | CACNA1C | Q13936 | 1/20 | 1.00 |
| ▸ | SCN9A | Q15858 | 1/20 | 1.00 |
| ▸ | SCN2A | Q99250 | 1/20 | 1.00 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ajmaline SCHEMBL29620363 | 1.00 | CYP2D6 (1.00) | CYP2D6KCNH2SCN5AKMT2AADRA2B | |
| Ajmaline SCHEMBL30116336 | 1.00 | CYP2D6 (1.00) | CYP2D6KCNH2SCN5AKMT2AADRA2B | |
| Ajmaline SCHEMBL30892623 | 1.00 | CYP2D6 (1.00) | CYP2D6KCNH2SCN5AKMT2AADRA2B | |
| Ajmaline SCHEMBL29811209 | 1.00 | CYP2D6 (1.00) | CYP2D6KCNH2SCN5AKMT2AADRA2B | |
| Ajmaline SCHEMBL14029381 | 1.00 | CYP2D6 (1.00) | CYP2D6KCNH2SCN5AKMT2AADRA2B | |
| Ajmaline SCHEMBL2787287 | 1.00 | CYP2D6 (1.00) | CYP2D6KCNH2SCN5AKMT2AADRA2B | |
| Ajmaline SCHEMBL23295973 | 1.00 | CYP2D6 (1.00) | CYP2D6KCNH2SCN5AKMT2AADRA2B | |
| Ajmaline SCHEMBL10422895 | 1.00 | CYP2D6 (1.00) | CYP2D6KCNH2SCN5AKMT2AADRA2B | |
| Ajmaline SCHEMBL29354066 | 1.00 | CYP2D6 (1.00) | CYP2D6KCNH2SCN5AKMT2AADRA2B | |
| Ajmaline SCHEMBL15384531 | 1.00 | CYP2D6 (1.00) | CYP2D6KCNH2SCN5AKMT2AADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 8708 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026041816-A1 | SIMULATION SYSTEM FOR EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) TREATMENT | FUNDACIÓ HOSPITAL UNIVERSITARI VALL D'HEBRON – INSTITUT DE RECERCA (ES) | 2026-02-26 | — | — | WO | claimed |
| US-20250195505-A1 | USE OF DEXTROMETHORPHAN IN COMBINATION WITH CYP2D6 AND CYP3A4 ENZYME INHIBITORS FOR THE TREATMENT OF PAIN | BIOBINA LLC | 2025-06-19 | — | — | US | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| US-12310934-B2 | Methods of treatment of spontaneous preterm birth | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-05-27 | — | — | US | claimed |
| US-20250161296-A1 | USE OF DEXTROMETHORPHAN IN COMBINATION WITH CYP2D6 AND CYP3A4 ENZYME INHIBITORS FOR THE TREATMENT OF PAIN | BIOBINA LLC | 2025-05-22 | — | — | US | claimed |
| US-12303503-B1 | Use of dextromethorphan in combination with CYP2D6 and CYP3A4 enzyme inhibitors for the treatment of pain | BIOBINA LLC (US) | 2025-05-20 | — | — | US | claimed |
| US-12117453-B2 | Predicting patient response to sodium channel blockers | WASHINGTON UNIVERSITY (US) | 2024-10-15 | — | — | US | claimed |
| US-20240279671-A1 | PLANTS EXHIBITING A PHENOTYPE UPON A CONTROLLED INDUCTION AND METHODS OF GENERATION THEREOF | PIGMENTIUM LTD (IL) | 2024-08-22 | — | — | US | claimed |
| CN-116930352-B | Liquid chromatography-mass spectrometry detection method for 37 common antiarrhythmic drugs in blood | 中国民用航空局民用航空医学中心 | 2024-02-23 | — | — | CN | claimed |
| WO-2024013418-A1 | DEVICE FOR MEASURING THE FILTRATION EFFICIENCY OF A MASK | TEXCON Y CALIDAD, S.L. (ES) | 2024-01-18 | — | — | WO | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| US-5811547-A | Method for inducing crystalline state transition in medicinal substance | NIPPON SHINYAJU CO., LTD. (JP) | 1998-09-22 | — | — | US | claimed |
| CN-1165005-A | Anti-neurosism preparation and its preparing technology | JIANGSU PROV MEDICINAL INDUSTR (CN) | 1997-11-19 | — | — | CN | claimed |
| EP-0580860-B1 | METHOD OF MANUFACTURING SOLID DISPERSION | NIPPON SHINYAKU CO LTD (JP) | 1997-10-22 | — | — | EP | claimed |
| US-4847260-A | NICOTINIC AND ISONITINIC ESTER ANTIARRHYTHMIA AGENTS FOR SKINS | NITTO DENKO CORPORATION (JP) | 1989-07-11 | — | — | US | claimed |
| US-4540602-A | Process for the preparation of activated pharmaceutical compositions | FREUND INDUSTRY COMPANY, LIMITED (JP) | 1985-09-10 | — | — | US | claimed |
| EP-0126043-A1 | Carbohydrate derivatives and compositions thereof for therapeutic or diagnostic use | ANDERSSON, Bengt (SE) | 1984-11-21 | — | — | EP | claimed |
| US-4175078-A | Cardenolide and bufadienolide derivatives of ajmaline and process for producing same | Kharkovsky Naucho-Issledovatelsky Khimfo-Farmatsevtiches-Ky Institut (SU) | 1979-11-20 | — | — | US | claimed |
| US-4148898-A | MYOCARDIUM INFARCT, VENTRICULAR AND SUPRAVENTRICULAR TACHYCARDIA | SOCIETE D'ETUDES ET DE RECHERCHES ENZYMOLOGIQUES ET PHARMACOLOGIQUES - ENZYPHA (FR) | 1979-04-10 | — | — | US | claimed |